Chan Yingleong, Salem Rany M, Hsu Yu-Han H, McMahon George, Pers Tune H, Vedantam Sailaja, Esko Tonu, Guo Michael H, Lim Elaine T, Franke Lude, Smith George Davey, Strachan David P, Hirschhorn Joel N
Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA; Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA 02115, USA; Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, MA 02115, USA.
Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA; Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA 02115, USA.
Am J Hum Genet. 2015 May 7;96(5):695-708. doi: 10.1016/j.ajhg.2015.02.018. Epub 2015 Apr 9.
Human height is a composite measurement, reflecting the sum of leg, spine, and head lengths. Many common variants influence total height, but the effects of these or other variants on the components of height (body proportion) remain largely unknown. We studied sitting height ratio (SHR), the ratio of sitting height to total height, to identify such effects in 3,545 African Americans and 21,590 individuals of European ancestry. We found that SHR is heritable: 26% and 39% of the total variance of SHR can be explained by common variants in European and African Americans, respectively, and global European admixture is negatively correlated with SHR in African Americans (r(2) ≈ 0.03). Six regions reached genome-wide significance (p < 5 × 10(-8)) for association with SHR and overlapped biological candidate genes, including TBX2 and IGFBP3. We found that 130 of 670 height-associated variants are nominally associated (p < 0.05) with SHR, more than expected by chance (p = 5 × 10(-40)). At these 130 loci, the height-increasing alleles are associated with either a decrease (71 loci) or increase (59 loci) in SHR, suggesting that different height loci disproportionally affect either leg length or spine/head length. Pathway analyses via DEPICT revealed that height loci affecting SHR, and especially those affecting leg length, show enrichment of different biological pathways (e.g., bone/cartilage/growth plate pathways) than do loci with no effect on SHR (e.g., embryonic development). These results highlight the value of using a pair of related but orthogonal phenotypes, in this case SHR with height, as a prism to dissect the biology underlying genetic associations in polygenic traits and diseases.
人类身高是一种综合测量指标,反映了腿长、脊柱长度和头长的总和。许多常见变异影响总体身高,但这些变异或其他变异对身高组成部分(身体比例)的影响仍大多未知。我们研究了坐高比(SHR),即坐高与总身高的比值,以在3545名非裔美国人和21590名欧洲血统个体中识别此类影响。我们发现SHR具有遗传性:欧洲人和非裔美国人中SHR总变异的26%和39%可分别由常见变异解释,并且全球欧洲血统混合比例与非裔美国人的SHR呈负相关(r²≈0.03)。六个区域与SHR的关联达到全基因组显著性水平(p<5×10⁻⁸),并且与生物学候选基因重叠,包括TBX2和IGFBP3。我们发现,670个与身高相关的变异中有130个与SHR名义上相关(p<0.05),这比偶然预期的更多(p = 5×10⁻⁴⁰)。在这130个位点上,增加身高的等位基因与SHR的降低(71个位点)或增加(59个位点)相关,这表明不同的身高位点对腿长或脊柱/头长的影响不成比例。通过DEPICT进行的通路分析表明,影响SHR的身高位点,尤其是那些影响腿长的位点,与对SHR无影响的位点(如胚胎发育)相比,显示出不同生物学通路(如骨骼/软骨/生长板通路)的富集。这些结果突出了使用一对相关但正交的表型(在这种情况下是SHR和身高)作为棱镜来剖析多基因性状和疾病中遗传关联背后生物学机制的价值。